CMRX earnings call for the period ending March 31, 2021.
Compare CMRX Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: Chimerix
CMRX earnings call for the period ending December 31, 2020.
A new acquisition could be quite the shot in the arm for the company.
Analyst price targets for these two biotechs suggest they could double your money. Here's what you need to know.
This once-promising clinical-stage company is trying to prove that it's not dead yet, but investors remain skeptical.
Analysts and investors continue to warm up to the company's shares after their December implosion.
Shares are recovering today from their massive sell-off, but the company's near-term future remains a mystery.
Here's why a brand management company, a marine shipper, and a biopharmaceutical were the worst-performing small company stocks in 2015.
Even as the market traded quietly, these stocks fell harder. Find out why.
The biopharma's shares imploded after the company's lead product candidate missed its primary endpoint in a late-stage study.